NextCell Pharma (NXTCL.ST) Stock Price
NextCell Pharma Price
Over the last 10 years NextCell Pharma grew revenue by 108.8% annually, reaching 10.94 M SEK. For NextCell Pharma, the net margin of -321.3% is up versus -627.9% a few years ago.
NextCell Pharma stock price
NextCell Pharma business model & stock analysis
Frequently asked questions about NextCell Pharma
Converted at the current exchange rate, the NextCell Pharma share trades at 0.10 EUR (1.10 SEK).
The NextCell Pharma share (NXTCL.ST) is listed on 3 stock exchanges, including: Frankfurt (65G.F), Stockholm (NXTCL.ST).
The revenue cannot currently be calculated for NextCell Pharma.
The expected profit of NextCell Pharma is -44.56 M SEK. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of NextCell Pharma is currently -2.75. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the NextCell Pharma stock.
The P/S cannot be calculated for NextCell Pharma currently.
The Eulerpool Quality Score for NextCell Pharma is 4/10.
The ISIN of NextCell Pharma is SE0009723125. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of NextCell Pharma is A2DSXP. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of NextCell Pharma is NXTCL.ST. The ticker symbol is used to trade NextCell Pharma shares on the stock exchange.
NextCell Pharma stock
NextCell Pharma Peer Group
NextCell Pharma Ticker
NextCell Pharma FIGI
All fundamentals and in-depth analysis of NextCell Pharma
Our stock analysis for NextCell Pharma stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of NextCell Pharma. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.